BioSpace News Archive

The AP report shows that in China, Mundipharma representatives are informing doctors that OxyContin is less addictive than other painkillers, which is a similar tactic the company used in the 1990s in the United States.

With the acquisition complete, Celgene is now a wholly-owned subsidiary of BMS. The combined companies have nine products with more than $1 billion in annual sales.

Pharma and biotech companies strengthen their leadership teams and boards with this week’s appointments.

Accumen has acquired three companies this year, allowing it to generate significant additional value for hospitals and health system, commercial laboratory, and health plan clients

Observational, multi-centre validation trial carried out in collaboration with a consortium of leading clinicians and clinical centres

Heidelberg Pharma contributing Antibody Targeted Amanitin Conjugate technology for Emergence Therapeutics antibody target

Invisian Medical awarded Innovative Technology group purchasing contract by Vizient to offer patent-pending Minne Ties fixation technology for jaw fractures and other jaw-related surgeries to its members

Pharnext SA, a biopharmaceutical company pioneering a new approach to developing innovative drug combinations based on big genomics data and artificial intelligence, announced the establishment of an equity line facility to enhance the Company’s financial flexibility and improve liquidity for shareholders.

Gut microbiome analysis experts Microba had three of their researchers – including both co-founders – named in the 2019 Highly Cited Researchers list by the Web of Science Group released yesterday.

Polyphor AG announced that Chairman of the Board Argeris “Jerry” Karabelas has resigned from the company for personal reasons, effective immediately.